期刊文献+

硫辛酸对急性肺损伤大鼠IL-10的影响 被引量:4

The effects of lipoicacid on interleukin-10 in acute lung injury rat
暂未订购
导出
摘要 目的探讨硫辛酸(LA)对内毒素(脂多糖,LPS)诱导的急性肺损伤(ALI)大鼠白细胞介素(IL)-10含量的影响。方法72只大鼠随机分为4组,对照组、LPS组LPS+LA30mg干预组。LPS+LA100mg干预组。各实验组舌下静脉注射LPS诱导大鼠ALI模型,30min后2个干预组分别给予LA30mg/kg和100mg/kg舌下静脉注射,对照组给予等体积生理盐水。LPS注射1、3、6h后测定血清及肺组织中IL-10浓度。结果各实验组血清及肺组织中IL-10分别在不同时间点显著高于对照组(P<0.01)。2个干预组血清及肺组织中IL-10水平在3h、6h明显升高,均显著高于LPS组(P<0.01),且LPS+LA100mg组显著高于LPS+LA30mg组(P<0.05)。结论LPS可导致ALI的发生,LA可提高IL-10水平,改善肺损伤。 Objective To investigate the effects of hpoicacid (LA)on expression of interleukin-10 (IL-10) in rat with acute lung injury (ALl) induced by lipopolysaccharide(LPS) .Methods 72 rats were randomly divided into four groups (normal group, LPS group, LPS + LA 30 mg group, LPS + LA 100 mg group). ALl model was made by hypoglossial injection of LPS, and 30 minutes later LA was injected in LPS + LA 30 mg group, and LPS + LA 100 mg goup. At 1,3 and 6h after LPS injection, the lung homogenates and serum were prepared to detect IL-10 levels. Results In LPS group, the levels of IL-10 in serum and lung homogenates were higher than those of normal goup ( P 〈 0.01 ) ,but lower than those of LPS + LA 30 mg group and LPS + LA 100 mg group at 3h and 6h after LPS injection ( P 〈 0.05). In LPS + LA 100 mg group, IL- 10 levels in serum and lung homogenates at 3h and 6h were higher than those of LPS+LA30mggoup( P 〈0.05).Conclusion LPScouldleadtoALI,LAcouldup-regulatelL-10 levels and improve the injury of lungs.
出处 《疑难病杂志》 CAS 2006年第5期322-324,共3页 Chinese Journal of Difficult and Complicated Cases
基金 河北省科学技术研究与发展项目(编号:052761712)
关键词 硫辛酸 脂多糖 肺损伤 急性 白细胞介素-10 大鼠 Lipoicacid Lipopolysaccharide Lung injury, acute Intedeukin- 10 Mouse
  • 相关文献

参考文献6

二级参考文献55

  • 1[1]Wolz P, Krieglstein J: Neuroprotective activity of lipoic and dihydrolipoic acid. In: Fuchs J, Packer L, Zimmer G, eds.Lipoic Acid in Health and Disease. New York: Marcel Dekker1997:205 - 225.
  • 2[2]Randie PJ: Regulatory interactions between lipids and carbohydrates:The glucose fatty acid cycle after 35 years. Diabetes Metab Rev 1998; 14:263 - 283.
  • 3[3]Betteridge DJ: What is oxidative stress? Metabolism 2000;49:3 - 8.
  • 4[4]Haffner SM: Clinical relevance of the oxidative stress concipt. Metabolism 2000; 49: 30 - 34.
  • 5[5]Christen Y:Oxidative stress and Alzheimer disease. Am J Clin Nutr 2000;71:621S-629S.
  • 6[6]Hartnett ME, Stratton RD, Browne RW, Rosner BA, Lanham RJ, Armstrong D: Serum markers for oxidative stress and severity of diabetic retnopathy. Diabetes Care 2000; 23: 234 -240.
  • 7[7]Ceriello A: Oxidative stress and glycemic regulation.Metabolism 2000; 49: 27 - 29.
  • 8[8]Wollheim CB: Beta-cell mitochondria in the regulation of insulin secretion: a new culprit in type Ⅱ diabetes. Diabetologia 2000 ;43 : 265 - 277.
  • 9[9]Fonseca V, Rosenstock J, Patwardhan R, Salzman A: Effect of metformin and rosiglitzzone combination therapy in patients with type 2 diabetes mellitus:A randomized controlled trial. J Am Med Assoc 2000;283:1695- 1702 .
  • 10[10]Yaworsky K, Somwar R, Ramlal T, Tritschler HJ, Kllp A: Engagement of the insulin-sensitive pathway in the stimulation of glucose transport by alphalipoic acid in 3T3 - L1 adipocytes.Diabetologia 2000 ;43:294 - 303.

共引文献68

同被引文献52

引证文献4

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部